Annual EBIT
-$1.57 M
NaN%
December 31, 2021
Summary
- As of February 9, 2025, BIOT annual earnings before interest & taxes is -$1.57 million
Performance
BIOT EBIT Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
High & Low
Earnings dates
Quarterly EBIT
-$246.60 K
+$1.02 M+80.50%
September 30, 2022
Summary
- As of February 9, 2025, BIOT quarterly earnings before interest & taxes is -$246.60 thousand, with the most recent change of +$1.02 million (+80.50%) on September 30, 2022.
- Over the past year, BIOT quarterly EBIT has increased by +$383.30 thousand (+60.85%).
Performance
BIOT Quarterly EBIT Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
High & Low
Earnings dates
TTM EBIT
-$3.74 M
+$383.30 K+9.30%
September 30, 2022
Summary
- As of February 9, 2025, BIOT TTM earnings before interest & taxes is -$3.74 million, with the most recent change of +$383.30 thousand (+9.30%) on September 30, 2022.
- Over the past year, BIOT TTM EBIT has dropped by -$2.50 million (-201.39%).
Performance
BIOT TTM EBIT Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
High & Low
Earnings dates
EBIT Formula
EBIT = Revenue − COGS − Operating Expenses
BIOT EBIT Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | - | +60.9% | -201.4% |
| 3 y3 years | - | - | - |
| 5 y5 years | - | - | - |
BIOT EBIT Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | at high | at low | at high | +669.3% | +138.1% | +10.3% |
| 5 y | 5-year | at high | at low | +67.6% | +669.3% | +2441.3% | +10.3% |
| alltime | all time | at high | at low | +67.6% | +669.3% | +2441.3% | +10.3% |
Biotech Acquisition EBIT History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2022 | - | -$246.60 K(-80.5%) | -$3.74 M(-9.3%) |
| Jun 2022 | - | -$1.26 M(-33.3%) | -$4.12 M(+24.1%) |
| Mar 2022 | - | -$1.90 M(+474.9%) | -$3.32 M(+111.4%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Dec 2021 | -$1.57 M | -$330.00 K(-47.6%) | -$1.57 M(+26.6%) |
| Sep 2021 | - | -$629.90 K(+36.0%) | -$1.24 M(+103.2%) |
| Jun 2021 | - | -$463.30 K(+215.0%) | -$610.40 K(+315.0%) |
| Mar 2021 | - | -$147.10 K | -$147.10 K |
FAQ
- What is Biotech Acquisition annual earnings before interest & taxes?
- What is the all time high annual EBIT for Biotech Acquisition?
- What is Biotech Acquisition quarterly earnings before interest & taxes?
- What is the all time high quarterly EBIT for Biotech Acquisition?
- What is Biotech Acquisition quarterly EBIT year-on-year change?
- What is Biotech Acquisition TTM earnings before interest & taxes?
- What is the all time high TTM EBIT for Biotech Acquisition?
- What is Biotech Acquisition TTM EBIT year-on-year change?
What is Biotech Acquisition annual earnings before interest & taxes?
The current annual EBIT of BIOT is -$1.57 M
What is the all time high annual EBIT for Biotech Acquisition?
Biotech Acquisition all-time high annual earnings before interest & taxes is -$1.57 M
What is Biotech Acquisition quarterly earnings before interest & taxes?
The current quarterly EBIT of BIOT is -$246.60 K
What is the all time high quarterly EBIT for Biotech Acquisition?
Biotech Acquisition all-time high quarterly earnings before interest & taxes is -$147.10 K
What is Biotech Acquisition quarterly EBIT year-on-year change?
Over the past year, BIOT quarterly earnings before interest & taxes has changed by +$383.30 K (+60.85%)
What is Biotech Acquisition TTM earnings before interest & taxes?
The current TTM EBIT of BIOT is -$3.74 M
What is the all time high TTM EBIT for Biotech Acquisition?
Biotech Acquisition all-time high TTM earnings before interest & taxes is -$147.10 K
What is Biotech Acquisition TTM EBIT year-on-year change?
Over the past year, BIOT TTM earnings before interest & taxes has changed by -$2.50 M (-201.39%)